5144 |
PHOSPHODIESTERASE 4D |
PDE4D |
ACRDYS2 |
DPDE3 |
HSPDE4D |
PDE43 |
PDE4DN2 |
STRK1 |
600129 |
8783 |
ENSG00000113448 |
OTTHUMG00000162218 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D |
Q08499 |
PDE4D_HUMAN |
CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (EC 3.1.4.17) (DPDE3) (PDE43). [SOURCE:UNIPROT/SWISSPROT;ACC:Q08499] |
PA33130 |
T02001 |
Interpro Type | Domain |
Uniprot Status | Swiss-Prot |
Uniprot Evidence | 1: Evidence at protein level |
Interpro Name | 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain |
Interpro Acc | IPR002073 |
Human Readable Name | DRUGGABLE GENOME |
Interpro Short Name | PDEase_catalytic_dom |
Target Class | Enzymes |
Target Subclass | EC:3.1.4.17 |
Target Subclass | 3.1.4.17 |
Target Main Class | Enzymes |
Gene Biotype | PROTEIN_CODING |
DRUGGABLE GENOME |
allosteric modulator |
inhibitor (inhibitory) |
Trial Name | - |
Novel drug target | Established target |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
Direct Interaction | yes |
antagonist (inhibitory) |
inhibitor (inhibitory) |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
Direct Interaction | yes |
n/a |
Trial Name | EHT 0202 |
Novel drug target | Established target |
inhibitor (inhibitory) |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | 3',5'-cyclic phosphodiesterase inhibitor |
Direct Interaction | yes |
n/a |
Trial Name | Resveratrol |
Novel drug target | Established target |
Trial Name | SRT501 |
inhibitor (inhibitory) |
Mechanism of Interaction | 3',5'-cyclic phosphodiesterase inhibitor |
Direct Interaction | yes |
PDE4D | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D (EC 3.1.4.17) (DPDE3) (PDE43). [SOURCE:UNIPROT/SWISSPROT;ACC:Q08499] | Description |
ENSG00000113448 | Ensembl Gene Id |
PDE4D | Display Id |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
PDE4D_HUMAN | Uniprot Id |
Q08499 | Uniprot Accession |
ENSG00000113448 | Ensembl Gene Id |
Target Subclass | 3.1.4.17 |
Target Main Class | Enzymes |
PDE4D | Gene Symbol |
Target Class | Enzymes |
Target Subclass | EC:3.1.4.17 |
PDE4D | Uniprot Gene Name |
5144 | Entrez Gene Id |
ENSG00000113448 | Ensembl Gene Id |
Interpro Type | Domain |
Uniprot Status | Swiss-Prot |
Uniprot Evidence | 1: Evidence at protein level |
DRUGGABLE GENOME |
PA33130 | PharmGKB ID |
PDE4D | TTD Gene Abbreviation |
T02001 | TTD Target ID |
ENSG00000113448 | Gene Symbol |
PDE4D | Ensembl Id |
DRUGGABLE GENOME |
DPDE3 | GENE_SYMBOL |
PDE4D | GENE_SYMBOL |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | UNIPROT |